Novel agents-based regimens as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials
Author:
Affiliation:
1. E.N.T. department; Weifang People's Hospital of Weifang Medical University; Weifang; China
2. Department of Hematology; Weifang People's Hospital of Weifang Medical University; Weifang; China
Publisher
Wiley
Subject
Cancer Research,Oncology,Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/hon.1007/fullpdf
Reference14 articles.
1. High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials;Koreth;Biol Blood Marrow Transplant,2007
2. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT;Bladé;Br J Haematol,1998
3. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints;Parmar;Stat Med,1998
4. Practical methods for incorporating summary time-to-event data into meta-analysis;Tierney;Trials,2007
5. First analysis of HOVON-65/GMMG-HD4 randomized phase III trial comparing bortezomib, adriamycin, dexamethasone (PAD) vs VAD as induction treatment prior to high dose melphalan (HDM) in patients with multiple myeloma (MM);Sonneveld;Haematologica,2009
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of age, sex, ethnicity, socio‐economic deprivation and novel pharmaceuticals on the overall survival of patients with multiple myeloma in New Zealand;British Journal of Haematology;2019-10-04
2. Autologous stem cell transplantation in multiple myeloma: Post-transplant outcomes of Taiwan Blood and Marrow Transplantation Registry;Journal of the Formosan Medical Association;2019-01
3. Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients;Leukemia;2017-06-30
4. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: An overview of systematic reviews with meta-analyses;Critical Reviews in Oncology/Hematology;2017-05
5. Outcomes of primary refractory multiple myeloma and the impact of novel therapies;American Journal of Hematology;2015-10-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3